Can-Fite BioPharma (CANF) Stock Chart & Stock Price History → FW: 234x Gain (From Weiss Ratings) (Ad) Free CANF Stock Alerts $2.15 +0.12 (+5.91%) (As of 11:19 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsSocial Media Can-Fite BioPharma Stock Price Performance5 Day Performance+2.53%1 Month Performance-11.35%3 Month Performance-2.87%6 Month Performance-6.67%Year-To-Date Performance-7.73%1 Year Performance+23.78% Receive CANF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Can-Fite BioPharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad StockEarningsThe AI Stock that’s Disrupting Every IndustryMove over Nvidia. There’s a new hot AI play that has soared 960% in the past year. One high-flying artificial intelligence stock has soared 960% over the past year and may soon become as familiar as Nvidia…Here's the Ticker >>> CANF Stock Chart for Friday, May, 3, 2024 CANF Chart by TradingView Can-Fite BioPharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/02/2024$2.09$2.03-2.87%$2.21$2.0110,915 shs$7.19 million05/01/2024$2.07$2.09+0.97%$2.12$2.0027,184 shs$7.40 million04/30/2024$1.97$2.07+5.08%$2.25$2.0045,441 shs$7.33 million04/29/2024$1.98$1.97-0.51%$2.02$1.958,739 shs$6.97 million04/26/2024$1.92$1.98+3.13%$2.01$1.918,664 shs$7.01 million04/25/2024$1.94$1.92-1.03%$1.97$1.9111,746 shs$6.80 million Get the Latest News and Ratings for CANF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Can-Fite BioPharma and its competitors with MarketBeat's FREE daily newsletter. 04/24/2024$2.01$1.94-3.48%$1.96$1.935,741 shs$6.87 million04/23/2024$1.98$2.01+1.52%$2.01$1.963,761 shs$7.12 million04/22/2024$1.98$1.98$2.05$1.918,684 shs$7.01 million04/19/2024$1.97$1.97$2.03$1.977,815 shs$6.97 million04/18/2024$1.96$1.97+0.51%$2.07$1.9610,456 shs$6.97 million04/17/2024$2.08$1.96-5.77%$2.11$1.9431,901 shs$6.94 million04/16/2024$2.10$2.08-0.95%$2.29$2.0313,200 shs$7.36 million04/15/2024$2.10$2.10$2.21$2.0220,092 shs$7.43 million04/12/2024$2.32$2.10-9.48%$2.34$2.1014,149 shs$7.43 million04/11/2024$2.35$2.32-1.28%$2.32$2.2011,675 shs$8.21 million04/10/2024$2.29$2.35+2.62%$2.42$2.2111,769 shs$8.32 million04/09/2024$2.40$2.29-4.58%$2.50$2.2620,911 shs$8.11 million04/08/2024$2.35$2.40+2.13%$2.50$2.299,801 shs$8.50 million04/05/2024$2.33$2.35+0.86%$2.57$2.2538,989 shs$8.32 million04/04/2024$2.29$2.33+1.75%$2.52$2.1532,290 shs$8.25 million04/03/2024$2.15$2.29+6.51%$2.32$2.215,112 shs$8.11 million04/02/2024$2.31$2.15-6.93%$2.38$2.0625,637 shs$7.61 million04/01/2024$2.22$2.31+4.05%$2.71$2.2274,844 shs$8.18 million03/29/2024$2.22$2.22$2.30$2.227,246 shs$7.86 million03/28/2024$2.26$2.22-1.77%$2.30$2.227,206 shs$7.86 million03/27/2024$2.18$2.26+3.67%$2.26$2.2111,263 shs$8 million03/26/2024$2.19$2.18-0.46%$2.26$2.188,066 shs$7.72 million03/25/2024$2.23$2.19-1.79%$2.24$2.1719,009 shs$7.75 million03/22/2024$2.19$2.23+1.83%$2.23$2.1217,758 shs$7.89 million03/21/2024$2.23$2.19-1.79%$2.23$2.1915,565 shs$7.75 million03/20/2024$2.18$2.23+2.29%$2.25$2.189,716 shs$7.89 million03/19/2024$2.19$2.18-0.46%$2.23$2.178,338 shs$7.72 million03/18/2024$2.12$2.19+3.30%$2.20$2.0415,338 shs$7.75 million03/15/2024$2.14$2.15+0.47%$2.17$2.122,100 shs$7.61 million03/14/2024$2.24$2.14-4.46%$2.25$2.1011,994 shs$7.58 million03/13/2024$2.14$2.24+4.67%$2.24$2.125,490 shs$7.93 million03/12/2024$2.25$2.14-4.89%$2.25$2.118,457 shs$7.58 million03/11/2024$2.21$2.25+1.81%$2.25$2.1618,757 shs$7.97 million03/08/2024$2.16$2.21+2.31%$2.25$2.1630,513 shs$7.82 millionThe AI Stock that’s Disrupting Every Industry (Ad)Move over Nvidia. There’s a new hot AI play that has soared 960% in the past year. One high-flying artificial intelligence stock has soared 960% over the past year and may soon become as familiar as Nvidia…Here's the Ticker >>>03/07/2024$2.13$2.16+1.41%$2.20$2.1039,452 shs$7.65 million03/06/2024$2.10$2.13+1.43%$2.20$2.0919,549 shs$7.54 million03/05/2024$2.14$2.10-1.87%$2.14$2.0312,418 shs$7.43 million03/04/2024$2.13$2.14+0.47%$2.14$2.0413,015 shs$7.58 million03/01/2024$2.14$2.13-0.47%$2.16$2.0613,034 shs$7.54 million02/29/2024$2.10$2.14+2.15%$2.14$2.087,685 shs$7.58 million02/28/2024$2.10$2.10-0.24%$2.15$2.0661,710 shs$7.42 million02/27/2024$2.10$2.10$2.10$2.0224,984 shs$7.43 million02/26/2024$2.06$2.10+1.94%$2.10$2.0728,134 shs$7.43 million02/23/2024$2.10$2.10$2.18$2.0668,265 shs$7.43 million02/22/2024$2.05$2.10+2.44%$2.10$2.0612,350 shs$7.43 million02/21/2024$2.07$2.05-0.97%$2.10$2.0115,943 shs$7.26 million02/20/2024$2.08$2.07-0.48%$2.09$2.007,036 shs$7.33 million02/19/2024$2.08$2.08+0.15%$2.10$2.015,200 shs$7.36 million02/16/2024$2.10$2.08-0.95%$2.10$2.015,268 shs$7.36 million02/15/2024$2.04$2.10+2.94%$2.15$2.069,393 shs$7.43 million02/14/2024$2.03$2.04+0.47%$2.13$2.027,824 shs$7.19 million02/13/2024$2.06$2.03-1.43%$2.05$2.0010,900 shs$7.19 million02/12/2024$2.06$2.06$2.12$2.0121,365 shs$7.29 million02/09/2024$2.00$2.06+3.00%$2.08$2.0025,785 shs$7.29 million02/08/2024$2.03$2.00-1.48%$2.08$2.008,185 shs$7.08 million02/07/2024$2.04$2.03-0.50%$2.10$2.0322,941 shs$7.19 million02/06/2024$2.01$2.04+1.50%$2.04$2.04835 shs$7.22 million02/05/2024$2.09$2.01-3.83%$2.13$2.0110,423 shs$7.12 million02/02/2024$2.06$2.09+1.46%$2.14$2.0122,961 shs$7.40 million Related Companies: BioRestorative Therapies Stock Price Chart Navidea Biopharmaceuticals Stock Price Chart PHAXIAM Therapeutics Stock Price Chart Eiger BioPharmaceuticals Stock Price Chart Galecto Stock Price Chart eFFECTOR Therapeutics Stock Price Chart Hepion Pharmaceuticals Stock Price Chart Chemomab Therapeutics Stock Price Chart Cadrenal Therapeutics Stock Price Chart Trevena Stock Price Chart Receive CANF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Can-Fite BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:CANF) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldThe AI stock to buy right nowStockEarningsFW: 234x GainWeiss RatingsUrgent Nvidia WarningAltimetryCould Your Accounts Be Frozen?Allegiance GoldDollar CancelledLear CapitalRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Can-Fite BioPharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.